EP2080502A1 - Dispositif d'emballage du type blister - Google Patents

Dispositif d'emballage du type blister Download PDF

Info

Publication number
EP2080502A1
EP2080502A1 EP08100536A EP08100536A EP2080502A1 EP 2080502 A1 EP2080502 A1 EP 2080502A1 EP 08100536 A EP08100536 A EP 08100536A EP 08100536 A EP08100536 A EP 08100536A EP 2080502 A1 EP2080502 A1 EP 2080502A1
Authority
EP
European Patent Office
Prior art keywords
conductor
blister pack
carrier
assembly according
pack assembly
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
EP08100536A
Other languages
German (de)
English (en)
Other versions
EP2080502B1 (fr
Inventor
Ulrich Moosheimer
Wolfgang Neft
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Schreiner Group GmbH and Co KG
Original Assignee
Schreiner Group GmbH and Co KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schreiner Group GmbH and Co KG filed Critical Schreiner Group GmbH and Co KG
Priority to EP08100536A priority Critical patent/EP2080502B1/fr
Priority to AT08100536T priority patent/ATE534365T1/de
Priority to EP09701699.2A priority patent/EP2242469B1/fr
Priority to PCT/EP2009/000177 priority patent/WO2009090048A1/fr
Publication of EP2080502A1 publication Critical patent/EP2080502A1/fr
Application granted granted Critical
Publication of EP2080502B1 publication Critical patent/EP2080502B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/03Containers specially adapted for medical or pharmaceutical purposes for pills or tablets
    • A61J1/035Blister-type containers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J2200/00General characteristics or adaptations
    • A61J2200/30Compliance analysis for taking medication

Definitions

  • the present invention relates to blister pack assemblies with a blister pack having cavities for holding one drug dose each - such as in the form of a tablet, a pill or a dragee - and a closure foil, each dose of medicament being pushable out by depressing the associated cavity for removal through the closure foil, in particular blister pack arrangements which additionally have a conductor carrier which has a conductor track and is aligned relative to the cavities of the blister pack such that the conductor path can be pressed out by at least one surface defined by vertical projection of one of the cavities onto the conductor carrier, through which the medicament dose of this cavity can be pushed out is, runs, so that the trace is interrupted by pushing out this drug dose through this area.
  • a completely separate interconnect loop can be provided for each cavity; or via each surface defined by vertical projection of one of the cavities on the conductor carrier, a branch of a parallel connection opens in two connections, and the number of withdrawn drug cans can be determined from the total resistance of the parallel connection whose reciprocal equals the sum of the reciprocals of the individual resistances of all intact branches is.
  • the conductor carrier which consists of a flat material such as a plastic film or a multilayer film composite.
  • the conductor carrier can in turn be glued to the sealing film of the blister pack.
  • a self-adhesive design of the conductor carrier is customary, which is presented on a sheet-like release material and then, usually mechanically, is applied to the sealing film of the blister pack.
  • a Blisterpackungsanordung of the type mentioned is from the German patent application DE 10 2004 060 213 A1 known.
  • Blisterpackungsanordung defined by vertical projection of one of the cavities on the conductor carrier surface is in each case surrounded annularly by punching lines.
  • the punched lines are interrupted by two formed from the flat material of the conductor carrier narrow web portions over which the conductor tracks out become.
  • this object is achieved by avoiding the tearing of a web part on the circumference of the surface defined by vertical projection of one of the cavities onto the conductor carrier.
  • the solution of the problem with a blister pack assembly according to claim 1 is implemented.
  • the rupture of a web portion on the circumference of the surface defined by vertical projection of one of the cavities on the conductor carrier is avoided in that the web part to be cut is laid in the area defined by vertical projection of the cavity on the conductor carrier.
  • Compared to the conventional design of a web portion at the edge of the plane defined by vertical projection of the cavity on the conductor carrier surface results in more favorable force introduction conditions, which tear the web part easier.
  • the solution of the underlying object is implemented with a blister pack arrangement according to claim 19.
  • the tearing of a web portion on the circumference of the defined by vertical projection of the cavities on the conductor carrier surface is avoided here, that is to interrupt the web no web part to break, but the conductor crosses a punching line facilitating the drug, without that at the intersection the punching line would be interrupted by a web part. So no web part has to be cut through at all.
  • Punching lines can basically be provided both in the form of simple punched lines, as well as in the form of gap-like recesses.
  • any variant of the invention described or indicated in the context of the present application may be particularly advantageous, depending on the economic and technical conditions in the individual case.
  • individual features of the described embodiments are interchangeable or can be combined with one another as well as with measures known per se from the prior art.
  • Fig. 1 the conductor carrier of a blister pack assembly according to the invention is shown in plan view.
  • stamping image of the Medication removal facilitating punching lines 3 summarized in a representation.
  • gap-like recesses can also be provided in partial areas. At the edge numbers are given from 1.1 to 1.10 for easier reference to the individual variants.
  • a common punching pattern will usually be selected for each drug dose to be withdrawn.
  • a desired conductor track guidance can allow the person skilled in the art to also access individually modified stamping images, for example for cavities 7 arranged at the corners of the blister pack.
  • the conductor carrier is made of a flat material 4, which is for example a plastic film (PET, PE, PP, PVC, PA ...), a film composite or paper can act.
  • the conductor tracks 1 are printed on the flat material 4.
  • Each cavity 7 is assigned its own conductor loop. Whether this is consistent, about the in Fig. 1 not detailed executed connections are queried at the edge of the conductor carrier shown below. For each cavity 7, a separate connection is provided so that it can be detected from which cavity 7 the drug dose contained therein was taken.
  • the printed conductors 1 and their connections can be carried out essentially as known from the prior art.
  • the conductor 1 is guided via a centrally arranged in the plane defined by vertical projection of the associated cavity 7 on the conductor carrier surface web portion 2.
  • the web part 2 is formed from the flat material 4 and defined by punched lines 3. Basically, this is already the narrow interruption of a punching line (as in Fig. 4 , Lower row shown) as a web part 2; in the embodiments of Fig. 1
  • the web part 2 is extended in each case by Stanzlinienfort accounts, which makes the web part 2 easier to tear.
  • the web part 2 may be further weakened by punching
  • the branching of the punching lines 3 also facilitates the tearing open of the flat material 4 in the region of the associated cavity 7 as a whole, when the tablet, pill or dragee arranged in the cavity 7 is pushed out of the cavity 7 by pressure.
  • the introduction of force is particularly favored by the fact that the web part 2 interrupts a punching line 3 which divides the surface defined by vertical projection of the associated cavity 7 on the strip carrier approximately into two halves (upper and lower in the illustration).
  • the punched lines 3 can lie completely within the area defined by vertical projection of the associated cavity 7 on the strip conductor carrier (variants 1.1 to 1.9), and also extend beyond them (variant 1.10).
  • FIGS. 2a-d and 3 Embodiments shown have punched lines 3, which each surrounded by vertical projection of the associated cavity 7 on the conductor carrier surface annularly.
  • the punching lines 3 are not interrupted by web parts 2, but overprinted directly with the conductors 1.
  • two foil layers 4a, 4b are provided with mutually offset punched lines 3a, 3b.
  • the in Fig. 2b and 2c illustrated, arranged above the Blisterkavtician 7 bottom film section 12 also missing.
  • the film layers 4a, 4b are glued together by means of an adhesive layer 9a.
  • the adhesive force of the adhesive layer 3b can be reduced or locally canceled.
  • this is possible by treating the adhesive with a so-called adhesive killer, overprinting the adhesive with a layer 10 or local printing of a film layer 4a, 4b with a non-stick coating, for example silicone paint.
  • the force with which the surface defined by vertical projection of the associated cavity 7 on the conductor carrier adheres to the remaining surface of the conductor carrier can be adjusted by a suitable choice of the distance between the offset punched lines 3a, 3b.
  • connection between the layers 4a and 4b may be provided, for example by means of a sealing layer, a bonding agent, welds, etc.
  • the conductor carrier can be glued by means of a further adhesive layer 9b on the sealing film 11 of the blister pack.
  • the cavities 7 of the blister pack are formed from a deep-drawn film 6.
  • the conductor 1 can, as in Fig. 2c-d shown, printed on top of the conductor carrier, but also on its underside, as in Fig. 2a shown, or between the film layers 4a, 4b, as in Fig. 2b shown.
  • the interconnects can also be connected via fewer connections than corresponds to the number of monitored drug cavities 7.
  • only four corresponding contact pads 8 are provided.
  • the number of withdrawn drug doses can be determined for each of the two parallel circuits from the total resistance of the parallel circuit whose reciprocal is equal to the sum of the reciprocal values of the individual resistances of all intact conductor paths branches.
  • Fig. 4 again shows two embodiments in a representation which analog Fig. 3 is constructed.
  • the guidance of the conductor 1 via web portions 2 is provided.
  • the web parts 2 are not extended by punching line extensions, which simplifies the stamping image.
  • Particularly favorable for the introduction of force is the arrangement of the punching lines 3 such that they approximately halve the areas defined by vertical projection of the associated cavities 7 on the conductor carrier.
  • the punching line 3 interrupting web parts 2 are provided.
  • the conductor 1 crosses the punching line directly.
  • the shape of the punch lines 3 which preclude spontaneous "unfolding"
  • a donation overlap as in FIG Fig. 2d shown, not required here. Rather, a version with only one film layer is possible.
  • Fig. 5 shows a further embodiment similar Fig. 3 ,
  • the stamped lines 3 here do not completely surround the surfaces defined by vertical projection of the associated cavities 7 on the strip conductor carrier, but form a kind of "doors".
  • On one side of the formed from the punching line 3 "door gap" is overprinted with the conductor track.
  • a similar Fig. 2d designed donation overlap be provided.
  • the film layer 4, 4a, 4b on which the printed conductor 1 is printed is printed as thin as possible, to use an elastic printed conductor material and / or to underlay the printed conductor with a lacquer or a printable composition.

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Packages (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
EP08100536A 2008-01-16 2008-01-16 Dispositif d'emballage du type blister Active EP2080502B1 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
EP08100536A EP2080502B1 (fr) 2008-01-16 2008-01-16 Dispositif d'emballage du type blister
AT08100536T ATE534365T1 (de) 2008-01-16 2008-01-16 Blisterpackungsanordung
EP09701699.2A EP2242469B1 (fr) 2008-01-16 2009-01-14 Dispositif d'emballage du type blister
PCT/EP2009/000177 WO2009090048A1 (fr) 2008-01-16 2009-01-14 Système d'emballage-coque

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP08100536A EP2080502B1 (fr) 2008-01-16 2008-01-16 Dispositif d'emballage du type blister

Publications (2)

Publication Number Publication Date
EP2080502A1 true EP2080502A1 (fr) 2009-07-22
EP2080502B1 EP2080502B1 (fr) 2011-11-23

Family

ID=39467197

Family Applications (2)

Application Number Title Priority Date Filing Date
EP08100536A Active EP2080502B1 (fr) 2008-01-16 2008-01-16 Dispositif d'emballage du type blister
EP09701699.2A Active EP2242469B1 (fr) 2008-01-16 2009-01-14 Dispositif d'emballage du type blister

Family Applications After (1)

Application Number Title Priority Date Filing Date
EP09701699.2A Active EP2242469B1 (fr) 2008-01-16 2009-01-14 Dispositif d'emballage du type blister

Country Status (3)

Country Link
EP (2) EP2080502B1 (fr)
AT (1) ATE534365T1 (fr)
WO (1) WO2009090048A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2484660A (en) * 2010-10-14 2012-04-25 Future Technology Uk Ltd Electrically Monitored Seal for a Blister Pack

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102011018199A1 (de) * 2011-04-19 2012-10-25 Schreiner Group Gmbh & Co. Kg Detektionselement für eine Blisterverpackung und Blisterverpackungseinheit
CN103413206B (zh) * 2013-08-28 2016-06-29 上海爱信诺航芯电子科技有限公司 一种适用于药板管理的智能rfid药板系统
US10930383B2 (en) 2015-07-03 2021-02-23 Cuepath Innovation Inc. Connected sensor substrate for blister packs
EP3316847B1 (fr) * 2015-07-03 2020-05-06 Cuepath Innovation Inc. Substrat de capteur connecté pour emballages-coques

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5412372A (en) * 1992-09-21 1995-05-02 Medical Microsystems, Inc. Article dispenser for monitoring dispensing times
EP1507248A1 (fr) 2003-08-14 2005-02-16 Schreiner Group GmbH & Co. KG Etiquette avec élément de suspension
DE102004060213A1 (de) 2003-12-19 2005-07-28 Udo Simon Blisterverpackungsanordnung
US6973371B1 (en) * 2004-10-13 2005-12-06 Nadir Benouali Unit dose compliance monitoring and reporting device and system
WO2007138520A1 (fr) * 2006-05-30 2007-12-06 Nxp B.V. Emballage-coque électronique

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0120018D0 (en) * 2001-08-16 2001-10-10 Meridica Ltd Pack containing medicament and dispensing device
ES2423288T3 (es) * 2008-05-22 2013-09-19 Wm. Wrigley Jr. Company Cubierta de envase blíster con muesca formada por láser dual

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5412372A (en) * 1992-09-21 1995-05-02 Medical Microsystems, Inc. Article dispenser for monitoring dispensing times
EP1507248A1 (fr) 2003-08-14 2005-02-16 Schreiner Group GmbH & Co. KG Etiquette avec élément de suspension
DE102004060213A1 (de) 2003-12-19 2005-07-28 Udo Simon Blisterverpackungsanordnung
US6973371B1 (en) * 2004-10-13 2005-12-06 Nadir Benouali Unit dose compliance monitoring and reporting device and system
WO2007138520A1 (fr) * 2006-05-30 2007-12-06 Nxp B.V. Emballage-coque électronique

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2484660A (en) * 2010-10-14 2012-04-25 Future Technology Uk Ltd Electrically Monitored Seal for a Blister Pack
GB2484660B (en) * 2010-10-14 2012-10-10 Future Technology Uk Ltd Seals
CN103415448A (zh) * 2010-10-14 2013-11-27 未来技术(英国)有限公司 密封件
US8973773B2 (en) 2010-10-14 2015-03-10 Future Technology (Uk) Ltd Seals
CN103415448B (zh) * 2010-10-14 2015-07-15 未来技术(英国)有限公司 用于储存和分发消费品的容器及与其一起使用的密封件

Also Published As

Publication number Publication date
EP2242469A1 (fr) 2010-10-27
ATE534365T1 (de) 2011-12-15
WO2009090048A1 (fr) 2009-07-23
EP2080502B1 (fr) 2011-11-23
EP2242469B1 (fr) 2016-05-04

Similar Documents

Publication Publication Date Title
DE69835292T2 (de) Vorrichtung zur detektierung einer arzneimittelabgabe
EP2059455B1 (fr) Emballage pour films contenant une substance active, et son procédé de fabrication
EP1947027B1 (fr) Habillage transparent et procédé de stockage temporaire de produits
DE60202458T2 (de) Kindergesicherte verpackung für pharmazeutische produkte
EP2242469B1 (fr) Dispositif d'emballage du type blister
DE10213594A1 (de) Einrichtung zur Erfassung der Produktentnahme durch eine elektronische Vorrichtung aus einer Verpackungsanordnung
EP0943138B1 (fr) Timbre transdermique medicamenteux autocollant mince
DE202004021140U1 (de) Neue Arzneimittelverpackung
EP0191168A2 (fr) Dispositif pour le stockage de médicaments et leur absorption provoquée en fonction du temps
DE69506267T2 (de) Blisterpackung mit trockenmittel
EP1737750A1 (fr) Dispositif d'emballage a blister
EP1770024A2 (fr) Emballage
DE2649316C2 (de) Doppelkammerbehälter zur Verabreichung von zwei Einzeldosen oder zweier Einzelkomponenten und Verfahren zu seiner Herstellung
EP1353857B1 (fr) Unite d'emballage primaire destinee a plusieurs comprimes pellicules individuels en tant que formes pharmaceutiques
DE3317549A1 (de) Geraet zum entnehmen von kapseln, tabletten oder dragees aus folienpackungen (blister)
DE102012104460A1 (de) Überrundumetikett zum Umkleben des Umfangs eines Gegenstandes
EP0139855A1 (fr) Dispositif pour l'application intra-anale de médicaments liquides ou en forme de pâte
EP1394600B1 (fr) Etiquette multicouche
EP0824478A1 (fr) Procede d'obtention d'articles maintenus sur un support, par exemple d'echantillons emballes, de cartes de credit, cartes d'identite et analogue
EP1474090A1 (fr) Systeme pour detecter au moyen d'un dispositif electronique le retrait de produits d'un emballage
EP2475592B1 (fr) Étiquette de protection destinée à protéger des médicaments contenus dans un emballage individuel
EP2874908B1 (fr) Emballage pour films contenant une dose unitaire d' une substance active ainsi que le procédé pour fabriquer cet emballage
EP1257481A1 (fr) Emballage pour objets plans, a dechirage ameliore
AT517369A1 (de) Behälter und Verband aus einer Anzahl von Behältern
WO2017158149A1 (fr) Dispositif d'administration de dose individuelle et procédé de production correspondant

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA MK RS

17P Request for examination filed

Effective date: 20091211

17Q First examination report despatched

Effective date: 20100118

AKX Designation fees paid

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

Free format text: NOT ENGLISH

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

Free format text: LANGUAGE OF EP DOCUMENT: GERMAN

REG Reference to a national code

Ref country code: CH

Ref legal event code: NV

Representative=s name: FREI PATENTANWALTSBUERO AG

REG Reference to a national code

Ref country code: NL

Ref legal event code: T3

REG Reference to a national code

Ref country code: DE

Ref legal event code: R096

Ref document number: 502008005645

Country of ref document: DE

Effective date: 20120216

LTIE Lt: invalidation of european patent or patent extension

Effective date: 20111123

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20111123

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120323

Ref country code: NO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120223

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20111123

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120323

Ref country code: LV

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20111123

Ref country code: SI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20111123

Ref country code: HR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20111123

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120224

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CY

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20111123

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BG

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120223

Ref country code: CZ

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20111123

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20111123

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20111123

Ref country code: EE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20111123

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: PL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20111123

Ref country code: RO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20111123

Ref country code: MC

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20120131

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

26N No opposition filed

Effective date: 20120824

REG Reference to a national code

Ref country code: DE

Ref legal event code: R097

Ref document number: 502008005645

Country of ref document: DE

Effective date: 20120824

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: ES

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120305

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20111123

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20111123

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: TR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20111123

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20120116

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: HU

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20080116

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 9

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 10

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 11

REG Reference to a national code

Ref country code: CH

Ref legal event code: PCAR

Free format text: NEW ADDRESS: POSTFACH, 8032 ZUERICH (CH)

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: AT

Payment date: 20200121

Year of fee payment: 13

Ref country code: IE

Payment date: 20200122

Year of fee payment: 13

Ref country code: NL

Payment date: 20200122

Year of fee payment: 13

Ref country code: IT

Payment date: 20200122

Year of fee payment: 13

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: CH

Payment date: 20200127

Year of fee payment: 13

Ref country code: BE

Payment date: 20200122

Year of fee payment: 13

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

REG Reference to a national code

Ref country code: NL

Ref legal event code: MM

Effective date: 20210201

REG Reference to a national code

Ref country code: AT

Ref legal event code: MM01

Ref document number: 534365

Country of ref document: AT

Kind code of ref document: T

Effective date: 20210116

REG Reference to a national code

Ref country code: BE

Ref legal event code: MM

Effective date: 20210131

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: AT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20210116

Ref country code: NL

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20210201

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20210131

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20210131

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20210116

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20210116

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20210131

P01 Opt-out of the competence of the unified patent court (upc) registered

Effective date: 20230515

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 20250120

Year of fee payment: 18

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 20250123

Year of fee payment: 18

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 20250123

Year of fee payment: 18